
Evaluation of Serum Amylase, Lipase, Lipid Profile and Insulin levels in Smokers
Author(s) -
Manikanta Reddy,
P Renuka,
B Jyothirmayi,
V. M Vinodhini
Publication year - 2022
Publication title -
ymer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.103
H-Index - 5
ISSN - 0044-0477
DOI - 10.37896/ymer21.04/58
Subject(s) - dyslipidemia , medicine , lipid profile , lipase , amylase , endocrinology , insulin , diabetes mellitus , endocrine system , pancreas , nicotine , enzyme , biology , hormone , biochemistry
ntroduction: Cigarette smoking is known to cause damage to many organs in the body. Nicotine may cause alterations in the exocrine and endocrine function of pancreas. This study aims to assess the effect of smoking on amylase, insulin levels and lipid profile in healthy smokers. Materials and Methods: 27 healthy smokers and 27 non- smokers were recruited as cases and controls. Fasting blood samples were collected for estimating the glucose, lipid profile, amylase, lipase and insulin levels. Results: There is a significant dyslipidemia, higher insulin levels and HOMA-IR and decrease in amylase and lipase levels in smokers compared to non- smokers. Conclusion: Smoking is associated with risk of development of diabetes mellitus and cardiovascular disease.